Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor

Background: Bipolar disorder (BD), or bipolar disease, is a prevalent psychiatric condition. Current treatment options are often ineffective, with numerous side effects. Brain-derived neurotrophic factor (BDNF) may be a potential biomarker for BD. Materials and Methods: Synthesized curcumin-conjugat...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahsa Salehirad, Fatemehsadat Mobinhosseini, A. Wallace Hayes, Malak Hekmati, Majid Motaghinejad, Mohammad Yousefi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-06-01
Series:Advanced Biomedical Research
Subjects:
Online Access:https://journals.lww.com/10.4103/abr.abr_253_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849236361212592128
author Mahsa Salehirad
Fatemehsadat Mobinhosseini
A. Wallace Hayes
Malak Hekmati
Majid Motaghinejad
Mohammad Yousefi
author_facet Mahsa Salehirad
Fatemehsadat Mobinhosseini
A. Wallace Hayes
Malak Hekmati
Majid Motaghinejad
Mohammad Yousefi
author_sort Mahsa Salehirad
collection DOAJ
description Background: Bipolar disorder (BD), or bipolar disease, is a prevalent psychiatric condition. Current treatment options are often ineffective, with numerous side effects. Brain-derived neurotrophic factor (BDNF) may be a potential biomarker for BD. Materials and Methods: Synthesized curcumin-conjugated ZnO nanoparticles (Cur-ZnO NPs) and curcumin-conjugated MgO nanoparticles (Cur-MgO NPs) were characterized by Fourier transform infrared, field emission scanning electron microscopy, (energy dispersive X-ray analysis (EDX), and ultraviolet-visible spectrophotometry. Behavioral changes in an open field test and the level of hippocampal BDNF were evaluated in a ketamine-induced manic-depressive-like behavior mouse model. Mice were treated intraperitoneal daily for 14 days. Control mice received saline; positive control mice received 25 mg/kg ketamine. Lithium (45 mg/kg), 5 mg/kg magnesium oxide (MgO), 5 mg/kg zinc oxide (ZnO), or 40 mg/kg curcumin was administrated in separates groups simultaneously with ketamine (25 mg/kg). Mice in the treatment group were given ketamine (25 mg/kg) plus Cur-MgO NPs or Cur-ZnO NPs (10, 20, or 40 mg/kg). Results: Both nanoparticles were chemically characterized. Both nanoparticles increased central square entries, time spent in the center zone, the rearing frequency, and ambulation distance in the ketamine-treated mice in the OFT. The hippocampal BDNF levels were also increased compared to the ketamine-treated mice. Conclusion: Cur-ZnO NPs and Cur-MgO NPs may be potential candidates for treating manic-depressive-like disorders.
format Article
id doaj-art-d8f7cf9395404fb29d2b74b1b4b56d84
institution Kabale University
issn 2277-9175
language English
publishDate 2025-06-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj-art-d8f7cf9395404fb29d2b74b1b4b56d842025-08-20T04:02:17ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752025-06-01141575710.4103/abr.abr_253_23Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic FactorMahsa SalehiradFatemehsadat MobinhosseiniA. Wallace HayesMalak HekmatiMajid MotaghinejadMohammad YousefiBackground: Bipolar disorder (BD), or bipolar disease, is a prevalent psychiatric condition. Current treatment options are often ineffective, with numerous side effects. Brain-derived neurotrophic factor (BDNF) may be a potential biomarker for BD. Materials and Methods: Synthesized curcumin-conjugated ZnO nanoparticles (Cur-ZnO NPs) and curcumin-conjugated MgO nanoparticles (Cur-MgO NPs) were characterized by Fourier transform infrared, field emission scanning electron microscopy, (energy dispersive X-ray analysis (EDX), and ultraviolet-visible spectrophotometry. Behavioral changes in an open field test and the level of hippocampal BDNF were evaluated in a ketamine-induced manic-depressive-like behavior mouse model. Mice were treated intraperitoneal daily for 14 days. Control mice received saline; positive control mice received 25 mg/kg ketamine. Lithium (45 mg/kg), 5 mg/kg magnesium oxide (MgO), 5 mg/kg zinc oxide (ZnO), or 40 mg/kg curcumin was administrated in separates groups simultaneously with ketamine (25 mg/kg). Mice in the treatment group were given ketamine (25 mg/kg) plus Cur-MgO NPs or Cur-ZnO NPs (10, 20, or 40 mg/kg). Results: Both nanoparticles were chemically characterized. Both nanoparticles increased central square entries, time spent in the center zone, the rearing frequency, and ambulation distance in the ketamine-treated mice in the OFT. The hippocampal BDNF levels were also increased compared to the ketamine-treated mice. Conclusion: Cur-ZnO NPs and Cur-MgO NPs may be potential candidates for treating manic-depressive-like disorders.https://journals.lww.com/10.4103/abr.abr_253_23bipolar disorderbrain-derived neurotrophic factornanoparticleopen field test
spellingShingle Mahsa Salehirad
Fatemehsadat Mobinhosseini
A. Wallace Hayes
Malak Hekmati
Majid Motaghinejad
Mohammad Yousefi
Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor
Advanced Biomedical Research
bipolar disorder
brain-derived neurotrophic factor
nanoparticle
open field test
title Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor
title_full Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor
title_fullStr Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor
title_full_unstemmed Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor
title_short Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor
title_sort curcumin zno and mgo nanoparticles confer protective effects against ketamine induced bipolar disorder in mice role of brain derived neurotrophic factor
topic bipolar disorder
brain-derived neurotrophic factor
nanoparticle
open field test
url https://journals.lww.com/10.4103/abr.abr_253_23
work_keys_str_mv AT mahsasalehirad curcuminznoandmgonanoparticlesconferprotectiveeffectsagainstketamineinducedbipolardisorderinmiceroleofbrainderivedneurotrophicfactor
AT fatemehsadatmobinhosseini curcuminznoandmgonanoparticlesconferprotectiveeffectsagainstketamineinducedbipolardisorderinmiceroleofbrainderivedneurotrophicfactor
AT awallacehayes curcuminznoandmgonanoparticlesconferprotectiveeffectsagainstketamineinducedbipolardisorderinmiceroleofbrainderivedneurotrophicfactor
AT malakhekmati curcuminznoandmgonanoparticlesconferprotectiveeffectsagainstketamineinducedbipolardisorderinmiceroleofbrainderivedneurotrophicfactor
AT majidmotaghinejad curcuminznoandmgonanoparticlesconferprotectiveeffectsagainstketamineinducedbipolardisorderinmiceroleofbrainderivedneurotrophicfactor
AT mohammadyousefi curcuminznoandmgonanoparticlesconferprotectiveeffectsagainstketamineinducedbipolardisorderinmiceroleofbrainderivedneurotrophicfactor